tirzepatide approval canada 🇨🇦 Health has approved Zepbound for the treatment of obstructive sleep apnea in adults living with obesity, making it the first and only GLP-1 medication in Canada approved for the sleep Zepbound approved in Canada for

Your appetite dropped

Insulin helps blood glucose enter your bodys cells for later energy use

It reduces HbA1c by an average of 2.3%-2.4% from baseline, reaching up to 2.58% in certain studies of 40-52 weeks in duration

Common recommendations include: Eating smaller, more frequent meals rather than large portions Avoiding late-evening meals (finishing dinner at least 3 hours before bedtime) Limiting known reflux triggers such as caffeine, alcohol, chocolate, mint, spicy foods, and high-fat meals Staying upright for at least 2-3 hours after eating Avoiding tight-fitting clothing around the abdomen Lifestyle modifications can significantly reduce reflux symptoms

What weight loss options are safe for breastfeeding mothers

Treatment with exenatide was implicated in EWDR in proportion to the reduction in HbA 1c [9], although retinopathy status was subsequently stable or improved in the majority of patients who continued treatment [10]